User profiles for Wen Shi Lee
 | Wen Shi LeeDepartment of Microbiology and Immunology, University of Melbourne Verified email at unimelb.edu.au Cited by 2797 |
[HTML][HTML] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
[HTML][HTML] Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …
[HTML][HTML] Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
Antibody-dependent cellular cytotoxicity against reactivated HIV-1-infected cells
WS Lee, J Richard, M Lichtfuss, AB Smith III… - Journal of …, 2016 - Am Soc Microbiol
Lifelong antiretroviral therapy (ART) for HIV-1 does not diminish the established latent reservoir.
A possible cure approach is to reactivate the quiescent genome from latency and utilize …
A possible cure approach is to reactivate the quiescent genome from latency and utilize …
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine
Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
[HTML][HTML] Systems serology detects functionally distinct coronavirus antibody features in children and elderly
KJ Selva, CE Van De Sandt, MM Lemke, CY Lee… - Nature …, 2021 - nature.com
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared
to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, …
to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, …
[HTML][HTML] Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination
elicit CD4 + T cell responses to the spike protein, including circulating follicular helper T (cT …
elicit CD4 + T cell responses to the spike protein, including circulating follicular helper T (cT …
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
Coronavirus disease 2019 (COVID-19) causes persistent endothelial inflammation, lung,
cardiovascular, kidney and neurological complications, and thromboembolic phenomena of …
cardiovascular, kidney and neurological complications, and thromboembolic phenomena of …
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Vaccination against SARS-CoV-2 protects from infection and improves clinical outcomes in
breakthrough infections, likely reflecting residual vaccine-elicited immunity and recall of …
breakthrough infections, likely reflecting residual vaccine-elicited immunity and recall of …
[HTML][HTML] Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
SARS-CoV-2 vaccines are advancing into human clinical trials, with emphasis on eliciting
high titres of neutralising antibodies against the viral spike (S). However, the merits of broadly …
high titres of neutralising antibodies against the viral spike (S). However, the merits of broadly …
